• Combination of two targeted drugs shows "clinically meaningful" activity in some malignant brain tumors

    11 days ago - By News Medical

    A combination of two targeted cancer drugs showed unprecedented, "clinically meaningful" activity in patients with highly malignant brain tumors that carried a rare genetic mutation, according to a clinical trial report by investigators from Dana-Farber Cancer Institute.
    Read more ...